No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs10877195 |
chr12:59359937-59359938 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs564148330 |
chr12:59360049-59360050 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs532674981 |
chr12:59360149-59360150 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs548043435 |
chr12:59360222-59360223 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs559814054 |
chr12:59360225-59360226 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs533763431 |
chr12:59360255-59360256 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs181206708 |
chr12:59360270-59360271 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs548376792 |
chr12:59360446-59360447 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs67446558 |
chr12:59360450-59360451 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs77597743 |
chr12:59360507-59360508 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs61919514 |
chr12:59360525-59360526 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs569812073 |
chr12:59360592-59360593 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs1148527 |
chr12:59360601-59360602 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs145107769 |
chr12:59360676-59360677 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs552273661 |
chr12:59360703-59360704 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs138868414 |
chr12:59360706-59360707 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs534730084 |
chr12:59360707-59360708 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs578102115 |
chr12:59360753-59360754 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs553198115 |
chr12:59360789-59360790 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs574792920 |
chr12:59360793-59360794 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs535596237 |
chr12:59360815-59360816 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs371425608 |
chr12:59360829-59360830 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs553830998 |
chr12:59360851-59360852 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs186520875 |
chr12:59360915-59360916 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs142000362 |
chr12:59360930-59360931 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs190290312 |
chr12:59360947-59360948 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs7957374 |
chr12:59360952-59360953 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs542250064 |
chr12:59361001-59361002 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs572765996 |
chr12:59361074-59361075 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs539859336 |
chr12:59361081-59361082 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs61224379 |
chr12:59361082-59361083 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs148080311 |
chr12:59361089-59361090 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs73118596 |
chr12:59361098-59361099 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs59693178 |
chr12:59361167-59361168 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs530892954 |
chr12:59361211-59361212 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs576634841 |
chr12:59361256-59361257 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs545368847 |
chr12:59361271-59361272 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs562162994 |
chr12:59361300-59361301 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs552610696 |
chr12:59361309-59361310 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs570872074 |
chr12:59361396-59361397 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs528445149 |
chr12:59361397-59361398 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs141827587 |
chr12:59361425-59361426 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs527823856 |
chr12:59361447-59361448 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs78067201 |
chr12:59361450-59361451 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs1823337 |
chr12:59361467-59361468 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs557175476 |
chr12:59361484-59361485 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs576144246 |
chr12:59361490-59361491 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs147812393 |
chr12:59361504-59361505 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs569046962 |
chr12:59361505-59361506 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs539274159 |
chr12:59361528-59361529 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|